Professor Thomas E Ferrin's lab focuses on creating advanced software tools for visualizing and analyzing complex molecular structures. Their primary program, ChimeraX, allows researchers to interact with detailed biological data, helping to uncover insights about diseases and drug targets. The lab aims to make these powerful tools accessible to scientists worldwide, enhancing our understanding of molecular biology and contributing to improvements in biomedical research.

Dr. Olivier Morin's lab focuses on improving treatment strategies for brain metastases in patients with non-small cell lung cancer. They are developing a personalized approach to predict brain metastases using advanced MRI techniques, aiming to minimize radiation exposure to healthy brain tissue. This research combines data from many patients to create a tailored treatment that can enhance patient survival and quality of life while reducing side effects from radiation therapy.

Dr. Melanie A Morrison's lab focuses on enhancing the success of deep brain stimulation (DBS) for Parkinson's disease patients. They are developing advanced MRI techniques to reliably predict how well patients will respond to DBS. By using a combination of different MRI imaging modalities, they aim to better inform doctors on which patients are the best candidates for this therapy, ultimately leading to improved outcomes and reduced risks of side effects.

Dr. Geeta J Narlikar's lab at UCSF focuses on understanding how chromatin, the material that makes up our DNA, is regulated in cells. They study both active and repressed states of chromatin, which are crucial for maintaining cellular identity and function. By investigating the mechanisms of chromatin remodeling and phase separation, the lab aims to discover how these processes relate to development and diseases, particularly cancer.

Dr. Yi Li's lab focuses on understanding brain injuries in newborns who suffer from a lack of oxygen at birth. They use advanced MRI techniques to study how different types of brain damage affect motor skills and language development in infants. The lab aims to improve diagnosis and treatment for these infants by developing better ways to predict their developmental outcomes based on MRI findings.

Dr. Eric J Huang’s lab at the University of California, San Francisco, focuses on understanding how defects in autophagy and endolysosomal trafficking contribute to neurodegenerative diseases, especially Frontotemporal Dementia (FTD). By studying the roles of microglia and their interactions with neurons, the lab investigates how these cellular processes may lead to neuronal loss and disease progression. The research combines molecular biology techniques with advanced proteomics to uncover new pathways that could lead to therapeutic targets for neurodegeneration.

Dr. William W. Seeley's lab at UCSF focuses on understanding the causes of frontotemporal dementia and motor neuron disease, two worsening neurodegenerative disorders. They investigate the role of certain proteins, like TDP-43, that misbehave in these conditions. By studying brain samples, they aim to find new insights that could lead to better treatments for these challenging diseases.

Dr. Karunesh Ganguly's lab at UCSF focuses on developing advanced brain-computer interfaces (BCIs) that can help patients with severe motor disabilities regain control of robotic arms. Their research specifically looks at using electrocorticography (ECoG), a method for recording brain activity, to enable paralyzed individuals to intuitively control robotic devices for tasks like reaching and grasping objects. This work aims to improve the quality of life for those affected by paralysis through innovative neuroprosthetic technology.

Dr. Martin Kampmann's lab at UCSF focuses on understanding the biological mechanisms behind Alzheimer's disease and related dementias. The lab investigates why certain neurons are more vulnerable to these diseases and explores potential therapeutic targets to improve resilience in these cells. They utilize advanced techniques including CRISPR and RNA sequencing to uncover the roles of specific genes and molecular pathways in neurodegeneration.

Dr. Suzanne Noble's research lab at UCSF focuses on understanding how certain fungi, particularly Candida species, colonize the human body without causing disease and how they can become pathogenic. The lab investigates the molecular mechanisms behind gut colonization by Candida albicans and skin colonization by Candida auris, helping to shed light on the transitions from harmless commensalism to pathogenicity. This research is crucial for developing strategies to manage fungal infections, especially those caused by drug-resistant strains.

Dr. David Julius's lab at UCSF focuses on understanding how we perceive pain through the study of specialized nerve fibers called nociceptors. His team investigates the molecular and physiological mechanisms that allow these nociceptors to detect harmful stimuli and transmit pain signals, especially in the context of chronic pain conditions like arthritis and gastrointestinal disorders. By combining advanced techniques from structural biology to integrative physiology, the lab aims to contribute to the development of new pain therapies and improve patients' quality of life.

Dr. Jeffrey Ohmann Bush's research lab at UCSF focuses on understanding how the cells shape the craniofacial structure during development and what goes wrong in craniofacial congenital anomalies. Using innovative techniques, including live imaging and CRISPR, the lab investigates the cellular behaviors and signaling mechanisms that lead to these birth defects. The goal is to translate this knowledge into improved therapeutic strategies for treating craniofacial conditions.

Dr. Megumi Okumura's lab focuses on improving the lives of young adults with autism spectrum disorder (ASD) by developing and assessing the effectiveness of a program called Resilience in Action (RiA). This program aims to enhance resilience, social skills, and overall well-being in young adults transitioning out of school systems. By conducting studies across multiple locations, the lab seeks to understand how resilience impacts mental health and social outcomes for these individuals.

Dr. Bridget Ostrem's lab at UCSF focuses on developing new treatments for premature infants suffering from white matter injury, a common and serious type of brain damage. The lab uses innovative screening methods to find compounds that can promote the repair of damaged brain cells and conduct clinical trials to test the safety and efficacy of these treatments. This research aims to provide effective therapies for conditions like cerebral palsy and learning disabilities that can arise from these injuries.

Dr. Rushika Perera's lab at UCSF focuses on understanding pancreatic cancer, specifically the mechanisms that allow these cancer cells to survive in harsh environments. The lab explores how certain proteins in lysosomes, which are the cell's waste disposal units, help pancreatic cancer cells grow and spread, even in nutrient-poor conditions. By investigating these processes, the lab aims to develop new treatment strategies targeting these proteins to combat this aggressive cancer.

Dr. David C. Perry's research lab focuses on understanding and improving the diagnosis and prognosis of behavioral variant frontotemporal dementia (bvFTD), a type of early-onset dementia. The lab studies patients over time to uncover clinical and biological differences that could help predict how the disease progresses. By combining neurological examinations, cognitive tests, and neuroimaging data, the goal is to enhance accurate diagnoses and tailor clinical care for patients and their families.

Dr. Alexander Pollen's lab at UCSF focuses on understanding how human brains are uniquely adapted to challenges like aging and stress. They study dopaminergic neurons, which are critical for movement and mood, to see how they cope with age-related stressors compared to those in other primates. By combining modern techniques like CRISPR and machine learning with stem cell-derived organoids, the lab aims to uncover the genetic changes that contribute to human brain plasticity and vulnerability to disorders.

Dr. Tanja Kortemme's lab at UCSF focuses on designing and engineering proteins to enhance their biological functions and correct errors in cellular processes. They use computational methods to create new proteins that can respond to signals within cells and investigate how existing proteins operate within cellular networks. This research not only aims to improve our understanding of biology but also to develop new strategies for therapeutic applications in medicine and biotechnology.

Dr. Louis J. Ptacek's lab focuses on understanding the genetics and biology behind sleep regulation, particularly for individuals with 'Familial Natural Short Sleep' (FNSS), a condition where affected people need significantly less sleep than average yet feel rested. The lab studies various genes involved in sleep homeostasis using human samples and mouse models, aiming to discover new genetic factors that play a role in sleep patterns. Ultimately, this research could lead to better treatments for sleep disorders.

Wensha Yang's lab focuses on improving radiation therapy for liver tumors by combining advanced imaging techniques with treatment planning strategies. They aim to minimize damage to healthy liver tissue while effectively targeting tumors, thereby reducing complications such as radiation-induced liver disease. Their innovative approach includes a novel MR imaging technique and optimizing treatment plans to enhance patient outcomes.